For example, BM-1197, a molecules that targeted Bcl-2 and inhibited the role of this protein on apoptosis, has been developed for the treatment of Diffuse large B cell lymphoma (DLBCL) [35]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.